(Q50501810)

English

Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.

scientific article published on 13 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Cibele M. Prado

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

object named as

Carla S Ceron

2

0 references

author name string

Elen Rizzi

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Danielle A Guimaraes

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Marcos A Rossi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Raquel F Gerlach

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Jose E Tanus-Santos

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

publication date

13 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

94

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

1-9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

ECM remodeling in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

The regulation of matrix metalloproteinases and their inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Rat models of hypertension, cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Angiotensin II induces MMP-2 in a p47phox-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Tissue inhibitor of metalloproteinases (TIMPs) in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Controversies in ventricular remodelling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

TGF-beta1 and angiotensin networking in cardiac remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix metalloproteinases: regulation and dysregulation in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Oxidative stress and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Identifiers

10.1016/J.YEXMP.2012.10.010

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23073243

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50501810&oldid=1370696688"